As of close of business last night, Structure Therapeutics Inc ADR’s stock clocked out at $35.11, down -4.75% from its previous closing price of $36.86. In other words, the price has decreased by -$1.75 from its previous closing price. On the day, 1087742 shares were traded. GPCR stock price reached its highest trading level at $37.57 during the session, while it also had its lowest trading level at $34.39.
Ratios:
To gain a deeper understanding of GPCR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 19.14 and its Current Ratio is at 19.14. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on October 19, 2023, initiated with a Mkt Outperform rating and assigned the stock a target price of $90.
On July 27, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $58.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GPCR now has a Market Capitalization of 1.71B and an Enterprise Value of 1.51B.
Stock Price History:
Over the past 52 weeks, GPCR has reached a high of $75.02, while it has fallen to a 52-week low of $21.12. The 50-Day Moving Average of the stock is 42.87, while the 200-Day Moving Average is calculated to be 42.77.
Shares Statistics:
It appears that GPCR traded 906.23K shares on average per day over the past three months and 869.11k shares per day over the past ten days. A total of 46.41M shares are outstanding, with a floating share count of 31.85M. Insiders hold about 11.31% of the company’s shares, while institutions hold 105.25% stake in the company. Shares short for GPCR as of Feb 15, 2024 were 2.5M with a Short Ratio of 2.76, compared to 2.22M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.39% and a Short% of Float of 6.41%.
Earnings Estimates
As of right now, 5 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.21 for the current quarter, with a high estimate of -$0.19 and a low estimate of -$0.22, while EPS last year was -$1.14. The consensus estimate for the next quarter is -$0.22, with high estimates of -$0.18 and low estimates of -$0.26.
Analysts are recommending an EPS of between -$0.83 and -$0.92 for the fiscal current year, implying an average EPS of -$0.87. EPS for the following year is -$0.93, with 6 analysts recommending between -$0.78 and -$1.1.
